Pharmacogenomics and Cardiovascular Disease

Pharmacogenomics and Cardiovascular Disease

Emily K. Dornblaser, Craig P. Worby, Daniel Alan Brazeau
ISBN13: 9781522571223|ISBN10: 1522571221|EISBN13: 9781522571230
DOI: 10.4018/978-1-5225-7122-3.ch010
Cite Chapter Cite Chapter

MLA

Dornblaser, Emily K., et al. "Pharmacogenomics and Cardiovascular Disease." Chronic Illness and Long-Term Care: Breakthroughs in Research and Practice, edited by Information Resources Management Association, IGI Global, 2019, pp. 184-197. https://doi.org/10.4018/978-1-5225-7122-3.ch010

APA

Dornblaser, E. K., Worby, C. P., & Brazeau, D. A. (2019). Pharmacogenomics and Cardiovascular Disease. In I. Management Association (Ed.), Chronic Illness and Long-Term Care: Breakthroughs in Research and Practice (pp. 184-197). IGI Global. https://doi.org/10.4018/978-1-5225-7122-3.ch010

Chicago

Dornblaser, Emily K., Craig P. Worby, and Daniel Alan Brazeau. "Pharmacogenomics and Cardiovascular Disease." In Chronic Illness and Long-Term Care: Breakthroughs in Research and Practice, edited by Information Resources Management Association, 184-197. Hershey, PA: IGI Global, 2019. https://doi.org/10.4018/978-1-5225-7122-3.ch010

Export Reference

Mendeley
Favorite

Abstract

Cardiovascular disease is one of the most prevalent disease states in the U.S. and contributes substantially to overall morbidity and mortality. The ability to effectively optimize the treatment of cardiovascular disease has a significant impact on overall disease prevention and treatment. This chapter discusses the relationship between genetic variations and their impact on medications used for the treatment of cardiovascular disorders. Key medications that are susceptible to genetic variation have been identified. The chapter describes the mechanisms by which genetic variation may contribute to altered medication concentrations or effects and briefly reviews the place in therapy for the cardiovascular medications. In addition, this chapter reviews current clinical literature to determine the overall impact these variations may have on clinical outcomes.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.